Plant Comparison
Saffron vs Dog-rose
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Saffron and Dog-rose: they share 6 indicated uses (arthritis / joint pain, cancer (anticancer research), cognitive function, …); 3 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Saffron | Dog-rose | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 10/10 | Stronger for Dog-rose |
| Cancer (anticancer research) | 8/10 | 2/10 | Stronger for Saffron |
| Cognitive function | 1/10 | 2/10 | Comparable evidence |
| Inflammation (general) | 1/10 | 8/10 | Stronger for Dog-rose |
| Metabolic support | 1/10 | 7/10 | Stronger for Dog-rose |
| Skin irritation | 1/10 | 7/10 | Stronger for Dog-rose |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Water-soluble carotenoid glycosides responsible for saffron's deep golden-red colour and much of its antioxidant and mood-related activity.
The principal volatile aromatic compound, giving saffron its characteristic scent and contributing to its sedative and antidepressant activity.
The main bitter-tasting glycoside of the stigma, a precursor of safranal.
The hip is exceptionally rich in vitamin C and carotenoids, underpinning its traditional tonic use. Quantified in commercial dried fruit at beta-carotene 7.25 mg/100 g and lycopene 2.34 mg/100 g fresh weight.
A specific galactolipid fraction studied as the likely active anti-inflammatory constituent in osteoarthritis trials of standardised rosehip powder.
Contribute to antioxidant activity. Leaves carry a higher total phenolic, flavonoid and phenolic-acid content than the hips, and leaf infusions were the only preparation to show antibacterial activity in vitro.
Cold-pressed rose hip seed oil is high in linolenic acid, with phytosterols up to 6485 mg/kg, tocopherols up to 1125 mg/kg and carotenoids up to 108 mg/kg; p-coumaric acid methyl ester predominates among its phenolics.
Pharmacological Actions
In vitro, the lipophilic (n-hexane and dichloromethane) rose hip extracts inhibited COX-1, COX-2 and 5-LOX-mediated leukotriene B4 formation; the aqueous and methanol extracts were inactive.
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anticancer action
inferred from neuroprotective action
inferred from anti-inflammatory action
inferred from sedative action
inferred from antidiabetic action
Two placebo-controlled crossover RCTs of standardised rosehip powder (5 g/day) report reduced WOMAC pain and reduced rescue-medication use in knee/hip osteoarthritis, consistent with the existing meta-analysis.
inferred from anticancer action
Animal evidence only. In high-fat-diet/streptozotocin diabetic rats, R. canina ethanol extract (250 mg/kg) improved recall and long-term memory and reduced hippocampal insulin resistance, amyloid-beta and acetylcholinesterase activity. No human data; the effect is reported in a diabetes model, not in healthy or cognitively impaired people.
inferred from anti-inflammatory action
inferred from anti-inflammatory action
One triple-blind placebo-controlled RCT (n=400) found that 500 mg R. canina fruit capsules twice daily for 20 days after caesarean section reduced the incidence of urinary tract infection. The incidence of cystitis specifically did not differ significantly between groups. Prevention in a post-surgical population; not evidence for treating an established UTI.
Safety, Cautions & Contraindications
Culinary use is entirely safe. At very high doses (5g+), saffron can be toxic — but such doses far exceed culinary or therapeutic amounts. Avoid medicinal doses during pregnancy (uterine stimulant). May interact with antidepressants. High quality saffron is often adulterated; verify source.
Duke (2002) rates saffron as ++ and provides a critical safety warning: abortifacient activity has clinical support (score 2), meaning that medicinal doses can induce abortion — saffron is strictly contraindicated in pregnancy at doses above culinary amounts. The plant also shows antidepressant, antioxidant, and antitumor activities at the experimental level (score 1). Dose (culinary): 0.5 g stigmas as flavoring; medicinal doses above 5 g are considered potentially toxic. Duke notes that saffron stigmas contain crocin and safranal, which are responsible for its antidepressant and antioxidant properties (Duke, 2002).
Rosa canina (dog rose) hips are generally recognized as safe (GRAS) for consumption, widely used in teas, jams, and supplements. They are highly nutritious but may cause minor digestive upset (nausea, diarrhea) in some users. The small, irritating hairs around the seeds should be removed before consumption.
Duke (2002) rates dog rose hips as +++ with clinical evidence (score 2) for astringent activity and experimental support for antioxidant and diuretic effects. Dog rose hips are exceptionally rich in vitamin C and bioflavonoids. They are traditionally used for cold and influenza prevention, urinary tract health, and mild diarrhea. Duke notes the diuretic (score 1) and lipoxygenase-inhibitory activities as experimentally documented. The fruit is considered food-grade safe (Duke, 2002).
External Ids
Botanical Description
Small, cormous perennial with narrow, grass-like, dark green leaves emerging with or just after the flowers. Each flower is a delicate lilac-purple, six-petalled bloom with three golden-yellow anthers and a single style dividing into three long, deep-red, thread-like stigmas - the saffron of commerce. The plant is a sterile triploid that never sets seed and is propagated entirely by division of its underground corms.
Scrambling, thorny deciduous shrub (Rosaceae), 1-5 m, with arching, prickly stems bearing hooked thorns. Leaves are pinnate with 5-7 oval, toothed leaflets. Pale pink to white, five-petalled flowers are followed by bright red-orange, egg-shaped hips (the fleshy hip is an accessory fruit; the true fruits are small hairy achenes inside it) that ripen in autumn and often persist into winter.[2]
Habitat
Believed to have originated in Greece or Crete and spread through cultivation across the Mediterranean, Middle East and Asia (notably Iran, Kashmir and Spain); grown in sunny, well-drained fields with hot, dry summers and cool, wet autumns/winters.
Native throughout Europe, north-west Africa and western Asia, common in hedgerows, woodland edges, scrub and roadside verges on a wide range of soils.[2]
Harvesting
The flowers are hand-picked at dawn as they open, and the three red stigma threads are immediately hand-separated from each flower and dried - an extremely labour-intensive process (many thousands of flowers are needed for a small amount of dried saffron), which accounts for saffron's high cost.
Hips are picked in autumn once fully coloured, then dried for tea or powder, or processed fresh for syrup. The fine, irritant hairs surrounding the seeds inside the hip must be removed before consumption.[5]
Traditional Uses
Saffron has a long Mediterranean, Middle Eastern and South Asian tradition as both a prized culinary spice/dye and a medicinal herb, used for mood support, digestive complaints and as a mild emmenagogue; its traditional mood-lifting reputation is now supported by clinical trials comparing standardised saffron extract to conventional antidepressants for mild-to-moderate depression.[1]
Rosehip has a long European folk tradition as a vitamin-C-rich tonic for colds and general immunity, and as a mild diuretic and astringent for urinary and digestive complaints. Modern clinical trials on standardised rosehip powder show a modest, reproducible benefit for osteoarthritis pain and stiffness.[1, 2]
Preparations
Dosage
Clinical trials for mood support commonly use around 30 mg of standardised saffron extract daily (in divided doses); culinary use is typically well under 1 g. High medicinal doses (5 g or more) are considered potentially toxic and should be avoided. Educational reference only, not a prescription.
Clinical trials for osteoarthritis have most often used around 5 g/day of standardised rosehip powder. Educational reference only, not a prescription.
References
Drug Class Interactions
Not documented
Lookalikes Review
Dangerous Lookalikes
Not documented
References & Sources
- Shafiee, A., Jafarabady, K., Seighali, N., Mohammadi, I. et al (2025) 'Effect of Saffron Versus Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment of Depression and Anxiety: A Meta-analysis of Randomized Controlled Trials', Nutrition Reviews, 83(3), pp. e751-e761. doi:10.1093/nutrit/nuae076 Meta-analysis / review
https://doi.org/10.1093/nutrit/nuae076 - Lopresti, A.L. and Drummond, P.D (2014) 'Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action', Human Psychopharmacology, 29(6), pp. 517-527. doi:10.1002/hup.2434 Meta-analysis / review
https://doi.org/10.1002/hup.2434 - Chen, Z., Gu, J., Lin, S., Xu, Z. et al (2022) 'Saffron essential oil ameliorates CUMS-induced depression-like behavior in mice via the MAPK-CREB1-BDNF signaling pathway', Journal of Ethnopharmacology, 300, pp. 115719. doi:10.1016/j.jep.2022.115719 Preclinical
https://doi.org/10.1016/j.jep.2022.115719 - Hausenblas, H.A., Saha, D., Dubyak, P.J. and Anton, S.D (2013) 'Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials', Journal of Integrative Medicine, 11(6), pp. 377-383. doi:10.3736/jintegrmed2013056 Meta-analysis / review
https://doi.org/10.3736/jintegrmed2013056 - Kell, G., Rao, A., Beccaria, G., Clayton, P., Inarejos-Garcia, A.M. and Prodanov, M (2017) 'affron a novel saffron extract (Crocus sativus L.) improves mood in healthy adults over 4 weeks in a double-blind, parallel, randomized, placebo-controlled clinical trial', Complementary Therapies in Medicine, 33, pp. 58-64. doi:10.1016/j.ctim.2017.06.001 Randomized trial
https://doi.org/10.1016/j.ctim.2017.06.001 - Baziar, S., Aqamolaei, A., Khadem, E., Mortazavi, S.H., Naderi, S., Sahebolzamani, E., Mortezaei, A., Jalilevand, S., Mohammadi, M., Shahmirzadi, M. and Akhondzadeh, S (2019) 'Crocus sativus L. Versus Methylphenidate in Treatment of Children with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Pilot Study', Journal of Child and Adolescent Psychopharmacology, 29(3), pp. 205-212. doi:10.1089/cap.2018.0146 Randomized trial
https://doi.org/10.1089/cap.2018.0146 - Moshiri, M., Vahabzadeh, M. and Hosseinzadeh, H (2014) 'Clinical Applications of Saffron (Crocus sativus) and its Constituents: A Review', Drug Research, 65(6), pp. 287-295. doi:10.1055/s-0034-1375681 Meta-analysis / review
https://doi.org/10.1055/s-0034-1375681 - Finley, J.W. and Gao, S (2017) 'A Perspective on Crocus sativus L. (Saffron) Constituent Crocin: A Potent Water-Soluble Antioxidant and Potential Therapy for Alzheimer's Disease', Journal of Agricultural and Food Chemistry, 65(5), pp. 1005-1020. doi:10.1021/acs.jafc.6b04398 Meta-analysis / review
https://doi.org/10.1021/acs.jafc.6b04398 - Boskabady, M.H. and Farkhondeh, T (2016) 'Antiinflammatory, Antioxidant, and Immunomodulatory Effects of Crocus sativus L. and its Main Constituents', Phytotherapy Research, 30(7), pp. 1072-1094. doi:10.1002/ptr.5622 Meta-analysis / review
https://doi.org/10.1002/ptr.5622 - Bhandari, P.R (2015) 'Crocus sativus L. (saffron) for cancer chemoprevention: A mini review', Journal of Traditional and Complementary Medicine, 5(2), pp. 81-87. doi:10.1016/j.jtcme.2014.10.009 Meta-analysis / review
https://doi.org/10.1016/j.jtcme.2014.10.009 - Khorasanchi, Z., Shafiee, M., Kermanshahi, F., Khazaei, M., Ryzhikov, M., Parizadeh, M.R., Kermanshahi, B., Ferns, G.A., Avan, A. and Hassanian, S.M (2018) 'Crocus sativus a natural food coloring and flavoring has potent anti-tumor properties', Phytomedicine, 43, pp. 21-27. doi:10.1016/j.phymed.2018.03.041 Meta-analysis / review
https://doi.org/10.1016/j.phymed.2018.03.041 - El Midaoui, A., Ghzaiel, I., Vervandier-Fasseur, D., Ksila, M., Zarrouk, A., Nury, T., Khallouki, F., El Hessni, A., Ibrahimi, S.O., Latruffe, N., Couture, R., Kharoubi, O., Brahmi, F., Hammami, S., Masmoudi-Kouki, O., Hammami, M., Ghrairi, T., Vejux, A. and Lizard, G (2022) 'Saffron (Crocus sativus L.): A Source of Nutrients for Health and for the Treatment of Neuropsychiatric and Age-Related Diseases', Nutrients, 14(3), pp. 597. doi:10.3390/nu14030597 Meta-analysis / review
https://doi.org/10.3390/nu14030597 - Pitsikas, N (2021) 'Crocus sativus L. Extracts and Its Constituents Crocins and Safranal; Potential Candidates for Schizophrenia Treatment?', Molecules, 26(5), pp. 1237. doi:10.3390/molecules26051237 Meta-analysis / review
https://doi.org/10.3390/molecules26051237 - Akhondzadeh, S. et al (2005) 'Comparison of Crocus sativus L'. Traditional / reference
https://scholar.google.com/scholar?q=Comparison%20of%20Crocus%20sativus%20L - Hosseinzadeh, H. and Nassiri-Asl, M (2013) 'Avicenna', 27(4), pp. 475--483. Traditional / reference
https://scholar.google.com/scholar?q=Avicenna - Moshiri, E. et al (2006) 'Crocus sativus L', pp. 607--611. Traditional / reference
https://scholar.google.com/scholar?q=Crocus%20sativus%20L - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Talaei, A., Hassanpour Moghadam, M., Sajadi Tabassi, S.A. and Mohajeri, S.A (2015) 'Crocin, the main active saffron constituent, as an adjunctive treatment in major depressive disorder: a randomized, double-blind, placebo-controlled, pilot clinical trial', Journal of Affective Disorders, 174, pp. 51-56. doi:10.1016/j.jad.2014.11.035 Randomized trial
https://doi.org/10.1016/j.jad.2014.11.035 - Toth, B., Hegyi, P., Lantos, T., Szakacs, Z., Keremi, B., Varga, G., Tenk, J., Petervari, E., Balasko, M., Rumbus, Z., Rakonczay, Z., Balint, E.R., Kiss, T. and Csupor, D (2019) 'The efficacy of saffron in the treatment of mild to moderate depression: a meta-analysis', Planta Medica, 85(1), pp. 24-31. doi:10.1055/a-0660-9565 Meta-analysis / review
https://doi.org/10.1055/a-0660-9565 - Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2024) 'Therapeutic potential of hypnotic herbal medicines: A comprehensive review', Phytotherapy Research, 38(6), pp. 3037-3059. doi:10.1002/ptr.8201 Meta-analysis / review
https://doi.org/10.1002/ptr.8201 - Block, K.I., Gyllenhaal, C. and Mead, M.N (2004) 'Safety and efficacy of herbal sedatives in cancer care', Integrative Cancer Therapies, 3(2), pp. 128-148. doi:10.1177/1534735404265003 Meta-analysis / review
https://doi.org/10.1177/1534735404265003 - Liu, J., Yang, Y. and Qi, Y (2024) 'Effect of saffron supplementation on the glycemic outcomes in diabetes: a systematic review and meta-analysis', Frontiers in Nutrition, 11, pp. 1349006. doi:10.3389/fnut.2024.1349006 Meta-analysis / review
https://doi.org/10.3389/fnut.2024.1349006 - Kupper, J. and Reichert, C (2009) 'Intoxications with plants', Therapeutische Umschau, 66(5), pp. 343-8. doi:10.1024/0040-5930.66.5.343 Clinical study
https://doi.org/10.1024/0040-5930.66.5.343 - Gabrscek, L. and Lesnicar, G. and Krivec, B. and Voga, G. and Sibanc, B. and Blatnik, J. and Jagodic, B (2004) 'Accidental poisoning with autumn crocus', Journal of Toxicology. Clinical Toxicology, 42(1), pp. 85-8. doi:10.1081/clt-120028750 Clinical study
https://doi.org/10.1081/clt-120028750 - University of Wisconsin-Madison Division of Extension 'Autumn Crocus, Colchicum spp'. Available at: https://hort.extension.wisc.edu/articles/autumn-crocus-colchicum-spp/ Traditional / reference
https://hort.extension.wisc.edu/articles/autumn-crocus-colchicum-spp/ - Ohio State University Extension (Buckeye Yard and Garden onLine) 'Crocus By Other Names'. Available at: https://bygl.osu.edu/node/1458 Traditional / reference
https://bygl.osu.edu/node/1458
- Christensen, R., Bartels, E.M., Altman, R.D., Astrup, A. and Bliddal, H (2008) 'Does the hip powder of Rosa canina (rosehip) reduce pain in osteoarthritis patients? - a meta-analysis of randomized controlled trials', Osteoarthritis and Cartilage, 16(9), pp. 965-972. doi:10.1016/j.joca.2008.03.001 Meta-analysis / review
https://doi.org/10.1016/j.joca.2008.03.001 - Gruenwald, J., Uebelhack, R. and More, M.I (2019) 'Rosa canina - Rose hip pharmacological ingredients and molecular mechanics counteracting osteoarthritis - A systematic review', Phytomedicine, 60, pp. 152958. doi:10.1016/j.phymed.2019.152958 Meta-analysis / review
https://doi.org/10.1016/j.phymed.2019.152958 - Sanz-Lamora, H., Nicola-Llorente, M., Torres-Oteros, D., Perez-Marti, A. and others (2024) 'The Antiobesity Effects of Rosehip (Rosa canina) Flesh by Antagonizing the PPAR Gamma Activity in High-Fat Diet-Fed Mice', Molecular Nutrition & Food Research, 68(5), pp. e2300539. doi:10.1002/mnfr.202300539 Preclinical
https://doi.org/10.1002/mnfr.202300539 - Tumbas, V.T., Canadanovic-Brunet, J.M., Cetojevic-Simin, D.D., Cetkovic, G.S. and others (2011) 'Effect of rosehip (Rosa canina L.) phytochemicals on stable free radicals and human cancer cells', Journal of the Science of Food and Agriculture, 92(6), pp. 1273-1281. doi:10.1002/jsfa.4695 Preclinical
https://doi.org/10.1002/jsfa.4695 - Pena, F., Valencia, S., Tereucan, G., Nahuelcura, J. and others (2023) 'Bioactive Compounds and Antioxidant Activity in the Fruit of Rosehip (Rosa canina L. and Rosa rubiginosa L.)', Molecules, 28(8), pp. 3544. doi:10.3390/molecules28083544 Preclinical
https://doi.org/10.3390/molecules28083544 - Hendrysiak, A., Brzezowska, J., Nicolet, N., Bocquel, D. and others (2023) 'Juice Powders from Rosehip (Rosa canina L.): Physical, Chemical, and Antiglycation Properties', Molecules, 28(4), pp. 1674. doi:10.3390/molecules28041674 Preclinical
https://doi.org/10.3390/molecules28041674 - Igual, M., Garcia-Herrera, P., Camara, R.M., Martinez-Monzo, J. and others (2022) 'Bioactive Compounds in Rosehip (Rosa canina) Powder with Encapsulating Agents', Molecules, 27(15), pp. 4737. doi:10.3390/molecules27154737 Preclinical
https://doi.org/10.3390/molecules27154737 - Truong, V.L. and Jeong, W.S (2023) 'Hair Growth-Promoting Effects of Rosehip (Rosa canina L.) Seed Oil in C57BL/6 Mice', Preventive Nutrition and Food Science, 28(4), pp. 411-417. doi:10.3746/pnf.2023.28.4.411 Preclinical
https://doi.org/10.3746/pnf.2023.28.4.411 - Michalska-Ciechanowska, A., Brzezowska, J., Nicolet, N., Haladyn, K. and others (2025) 'Valorization of Rosehip (Rosa canina L.) Pomace Using Unconventional Carbohydrate Carriers for Beverage Obtainment', Molecules, 30(1), pp. 141. doi:10.3390/molecules30010141 Preclinical
https://doi.org/10.3390/molecules30010141 - Vlaicu, P.A., Untea, A.E., Turcu, R.P., Panaite, T.D. and Saracila, M (2022) 'Rosehip (Rosa canina L.) Meal as a Natural Antioxidant on Lipid and Protein Quality and Shelf-Life of Polyunsaturated Fatty Acids Enriched Eggs', Antioxidants (Basel), 11(10), pp. 1948. doi:10.3390/antiox11101948 Preclinical
https://doi.org/10.3390/antiox11101948 - Phetcharat, L. and Wongsuphasawat, K. and Winther, K (2015) 'The effectiveness of a standardized rose hip powder, containing seeds and shells of Rosa canina, on cell longevity, skin wrinkles, moisture, and elasticity', Clinical Interventions in Aging, 10, pp. 1849--1856. doi:10.2147/CIA.S90092 Randomized trial
https://doi.org/10.2147/CIA.S90092 - Golsorkhi, H. and Montazerlotfelahi, H. and Abniki, E. and Vafaee-Shahi, M. and Kamalinejad, M. and Qorbani, M. and Bahrami, M. and Dadmehr, M (2025) 'Efficacy and safety of Rosa canina L. and a traditional polyherbal formulation syrup in children and adolescents with attention-deficit/hyperactivity disorder: a factorial randomized double-blind placebo-controlled clinical trial', Phytotherapy Research, 39(9), pp. 4116--4125. doi:10.1002/ptr.70061 Randomized trial
https://doi.org/10.1002/ptr.70061 - Miljkovi\'c, V. M. and Nikoli\'c, L. and Mrmo\v sanin, J. and Gaji\'c, I. and Mihajilov-Krstev, T. and Zvezdanovi\'c, J. and Miljkovi\'c, M (2024) 'Chemical profile and antioxidant and antimicrobial activity of Rosa canina L. dried fruit commercially available in Serbia', International Journal of Molecular Sciences, 25(5), pp. 2518. doi:10.3390/ijms25052518 Preclinical
https://doi.org/10.3390/ijms25052518 - Polumackanycz, M. and Kaszuba, M. and Konopacka, A. and Marzec-Wr\'oblewska, U. and Wesolowski, M. and Waleron, K. and Buci\'nski, A. and Viapiana, A (2020) 'Phenolic composition and biological properties of wild and commercial dog rose (Rosa canina L.) fruits and leaves', Molecules, 25(22), pp. 5272. doi:10.3390/molecules25225272 Preclinical
https://doi.org/10.3390/molecules25225272 - Grajzer, M. and Prescha, A. and Korzonek, K. and Wojakowska, A. and Dziadas, M. and Kulma, A. and Grajeta, H (2015) 'Characteristics of rose hip (Rosa canina L.) cold-pressed oil and its oxidative stability studied by the differential scanning calorimetry method', Food Chemistry, 188, pp. 459--466. doi:10.1016/j.foodchem.2015.05.034 Preclinical
https://doi.org/10.1016/j.foodchem.2015.05.034 - Chrubasik, C., Roufogalis, B.D., Müller-Ladner, U. and Chrubasik, S (2008) 'A systematic review on the Rosa canina effect and efficacy profiles', 22(6), pp. 725--733. doi:10.1002/ptr.2400 Meta-analysis / review
https://doi.org/10.1002/ptr.2400 - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - Wenzig, E. M. and Widowitz, U. and Kunert, O. and Chrubasik, S. and Bucar, F. and Knauder, E. and Bauer, R (2008) 'Phytochemical composition and in vitro pharmacological activity of two rose hip (Rosa canina L.) preparations', Phytomedicine, 15(10), pp. 826--835. doi:10.1016/j.phymed.2008.06.012 Preclinical
https://doi.org/10.1016/j.phymed.2008.06.012 - Winther, K. and Apel, K. and Thamsborg, G (2005) 'A powder made from seeds and shells of a rose-hip subspecies (Rosa canina) reduces symptoms of knee and hip osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial', Scandinavian Journal of Rheumatology, 34(4), pp. 302--308. doi:10.1080/03009740510018624 Randomized trial
https://doi.org/10.1080/03009740510018624 - Rein, E. and Kharazmi, A. and Winther, K (2004) 'A herbal remedy, Hyben Vital (stand. powder of a subspecies of Rosa canina fruits), reduces pain and improves general wellbeing in patients with osteoarthritis: a double-blind, placebo-controlled, randomised trial', Phytomedicine, 11(5), pp. 383--391. doi:10.1016/j.phymed.2004.01.001 Randomized trial
https://doi.org/10.1016/j.phymed.2004.01.001 - Ertas, B. and Hazar-Yavuz, A. N. and Topal, F. and Keles-Kaya, R. and Karakus, \"O. and Ozcan, G. S. and Taskin, T. and Cam, M. E (2023) 'Rosa canina L. improves learning and memory-associated cognitive impairment by regulating glucose levels and reducing hippocampal insulin resistance in high-fat diet/streptozotocin-induced diabetic rats', Journal of Ethnopharmacology, 313, pp. 116541. doi:10.1016/j.jep.2023.116541 Preclinical
https://doi.org/10.1016/j.jep.2023.116541 - Seifi, M. and Abbasalizadeh, S. and Mohammad-Alizadeh-Charandabi, S. and Khodaie, L. and Mirghafourvand, M (2017) 'The effect of Rosa (L. Rosa canina) on the incidence of urinary tract infection in the puerperium: a randomized placebo-controlled trial', Phytotherapy Research, 32(1), pp. 76--83. doi:10.1002/ptr.5950 Randomized trial
https://doi.org/10.1002/ptr.5950 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.